Atlas Trials

Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Clinical trial NCT01454024 · COMPLETED

Trial details

NCT number
NCT01454024
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems
Start date
2011-11-01
Primary completion
2012-10-01
Enrollment
1031

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.